Aspen strikes deal with Indian company to cut cost of HIV medicine | Fin24
  • Peter Moyo

    The ex-Old Mutual boss has been treated badly, but is still overplaying his hand, says Ferial Haffajee.

  • 'Nosedive'

    We don't use fake parts, says South African Airways, after mid-air 'jolt'.

  • Fin24’s newsletter

    Sign up to receive Fin24's top news in your inbox every morning.


Aspen strikes deal with Indian company to cut cost of HIV medicine

Sep 20 2019 10:24
Loni Prinsloo

Aspen Pharmacare [JSE:APN] agreed to a partnership with India’s Laurus Labs to boost supply of active pharmaceutical ingredients that will help reduce the cost of HIV drugs.

The Durban-based company plans to licence intellectual property rights owned by Laurus, executive Stavros Nicolaou said by phone on Friday. The Indian company will gain a trading entity in South Africa as part of the deal, he said.

The move will put Aspen in a better position to bid for government contracts as the country plans to scale up treatment to 6 million people, Nicolaou said. The deal was first reported by Business Day newspaper.

The shares rose 0.3% on Friday morning on the JSE. 



Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

What do you think about private healthcare in SA?

Previous results · Suggest a vote